CytexOrtho (Equity)

Funding Details
Awarder
StartEngine
Date Award
June 13, 2024
Vertical
Healthcare
Funding URL
View Funding Page
Premoney Valuation
$1,000,000
Valuation
$18,180,000

Company Info
Founding Year
Not provided
Traction
CytexOrtho has won numerous state and federal grants recognizing the novelty of their research and products’ enormous potential to transform joint care. The co-founders of CytexOrtho recently won the Kappa Delta Elizabeth Winston Lanier award from the American Academy of Orthopaedic Surgeons (AAOS).
Organizations Involved
None
Founders
Bradley Estes, Franklin Moutos, Farshid Guilak
Company Description
CytexOrtho is a healthcare startup that is developing technology and solutions for younger patients with hip pain to address early joint degeneration. The company’s lead product is a cutting-edge biodegradable medical implant that restores joint cartilage and bone instead of replacing it with artificial materials found in a total joint replacement. While this product is not yet commercially available, CytexOrtho is currently preparing for an FDA IDE submission to begin clinical trials for it and expects to begin these trials in 2023.
Market
Orthopedics
Location
Durham, NC, US
Coinvestors
None

Links
Back to Home Back to Healthcare Deals View Funding Announcement